Skip to main content
. 2020 Jan 24;19(3):2533–2538. doi: 10.3892/ol.2020.11259

Table I.

General information of patients in two groups.

Factors Experimental group (n=47) Control group (n=53) Statistic P-value
Age, n (%) 0.036 0.851
  ≤50 16 (34.04) 19 (35.85)
  >50 31 (65.96) 34 (64.15)
Sex, n (%) 0.040 0.841
  Male 24 (51.06) 26 (49.06)
  Female 23 (48.94) 27 (50.94)
ASA classification, n (%) 0.134 0.715
  Grade II 24 (51.06) 29 (54.72)
  Grade III 23 (48.94) 24 (45.28)
BMI (kg/m2), n (%) 0.001 0.971
  ≤21 25 (53.19) 28 (52.83)
  >21 22 (46.81) 25 (47.17)
Tumor location, n (%) 0.004 0.952
  Left colon 21 (44.68) 24 (45.28)
  Right colon 26 (55.32) 29 (54.72)
Tumor maximum diameter (cm), n (%) 0.097 0.756
  ≤5 12 (25.53) 15 (28.30)
  >5 35 (74.47) 38 (71.70)
Pathological type, n (%)
  Adenocarcinoma 14 (29.79) 16 (30.19) 0.048 0.826
  Colloid carcinoma 16 (34.04) 19 (35.85) 0.036 0.850
  Undifferentiated carcinoma 17 (36.17) 18 (33.96) 0.053 0.817
Stagings, n (%) 0.655 0.418
  I–II 37 (78.72) 38 (71.70)
  III–IV 10 (21.28) 15 (28.30)
Negative emotion score
  SAS 49.61±8.72 50.07±8.65 0.264 0.792
  SDS 50.23±8.61 50.19±8.24 0.024 0.981
Anesthesia duration (min) 130.78±41.21 129.69±40.17 0.134 0.894
Operation duration (min) 96.88±12.98 97.67±13.12 0.303 0.763